The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy-Reference-Cited by-同舟云学术

The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy

Published:2020-05-26 Issue:21 Volume:11 Page:1953-1960
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Galvez Carlos¹,Jacob Saya²,Finkelman Brian S.³,Zhao Jeffrey⁴,Tegtmeyer Kyle⁴,Chae Young Kwang¹⁵,Mohindra Nisha¹⁵,Salgia Ravi⁶,Jovanovic Borko⁴,Behdad Amir³,Villaflor Victoria¹⁵

Affiliation:

1. Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

2. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

3. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

4. Northwestern University, Chicago, IL, USA

5. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA

6. City of Hope Comprehensive Cancer Center, Los Angeles, CA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study;Japanese Journal of Clinical Oncology;2024-09-11

2. Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection;Cancers;2023-11-30

3. Prise en charge des stades précoces : place des thérapies ciblées en périopératoire;Revue des Maladies Respiratoires Actualités;2023-10

4. A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma;BMC Cancer;2023-09-11

5. Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma;JTO Clinical and Research Reports;2023-09